Literature DB >> 18575820

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No.

Guido Finazzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18575820     DOI： 10.1007/s11739-008-0169-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  15 in total

1.  Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.

Authors:  Emily Somers; Laurence S Magder; Michelle Petri
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients.

Authors:  N M Shah; M A Khamashta; T Atsumi; G R Hughes
Journal:  Lupus       Date:  1998       Impact factor: 2.911

4.  A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

Authors:  G Finazzi; R Marchioli; V Brancaccio; P Schinco; F Wisloff; J Musial; F Baudo; M Berrettini; S Testa; A D'Angelo; G Tognoni; T Barbui
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

5.  A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis.

Authors:  R Forastiero; M Martinuzzo; G Pombo; D Puente; A Rossi; L Celebrin; S Bonaccorso; L Aversa
Journal:  J Thromb Haemost       Date:  2005-06       Impact factor: 5.824

6.  Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.

Authors:  G Finazzi; V Brancaccio; M Moia; N Ciaverella; M G Mazzucconi; P C Schinco; M Ruggeri; E M Pogliani; G Gamba; E Rossi; F Baudo; C Manotti; A D'Angelo; G Palareti; V De Stefano; M Berrettini; T Barbui
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

7.  Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

Authors:  José A Girón-González; Enrique García del Río; Carmen Rodríguez; Javier Rodríguez-Martorell; Ascensión Serrano
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

8.  Efficacy and safety of low-dose aspirin in polycythemia vera.

Authors:  Raffaele Landolfi; Roberto Marchioli; Jack Kutti; Heinz Gisslinger; Gianni Tognoni; Carlo Patrono; Tiziano Barbui
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

9.  Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.

Authors:  Monica Galli; Giovanna Borrelli; Eva Marie Jacobsen; Rosa Maria Marfisi; Guido Finazzi; Roberto Marchioli; Finn Wisloff; Stefana Marziali; Olivier Morboeuf; Tiziano Barbui
Journal:  Blood       Date:  2007-04-17       Impact factor: 22.113

10.  The management of thrombosis in the antiphospholipid-antibody syndrome.

Authors:  M A Khamashta; M J Cuadrado; F Mujic; N A Taub; B J Hunt; G R Hughes
Journal:  N Engl J Med       Date:  1995-04-13       Impact factor: 91.245
View more
  5 in total

1.  Aspirin thromboprophylaxis of asymptomatic antiphospholipid-positive subjects.

Authors:  Monica Galli
Journal:  Intern Emerg Med       Date:  2008-11-21       Impact factor: 3.397

2.  Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients.

Authors:  Mario Bazzan; Antonella Vaccarino
Journal:  Intern Emerg Med       Date:  2008-12-12       Impact factor: 3.397

3.  25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies.

Authors:  Laura Andreoli; Angela Tincani
Journal:  Intern Emerg Med       Date:  2009-01-08       Impact factor: 3.397

4.  Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies.

Authors:  Stefania Basili; Francesco Violi
Journal:  Intern Emerg Med       Date:  2008-09-10       Impact factor: 3.397

Review 5.  Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety.

Authors:  Nahid A Qushmaq; Samar A Al-Emadi
Journal:  ISRN Rheumatol       Date:  2014-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.